tradingkey.logo
搜尋

Azenta Inc

AZTA
添加自選
16.020USD
-0.780-4.64%
收盤 05/15, 16:00美東報價延遲15分鐘
738.38M總市值
虧損本益比TTM

Azenta Inc

16.020
-0.780-4.64%
查看詳細走勢圖
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-4.64%

5天

-16.65%

1月

-34.13%

6月

-46.15%

今年開始到現在

-51.83%

1年

-41.68%

TradingKey Azenta Inc股票評分

單位: USD 更新時間: 2026-05-15

操作建議

Azenta Inc當前公司基本面數據相對非常健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在生物技術與醫療研究行業排名28/382位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為28.50。中期看,股價處於下降通道。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Azenta Inc評分

相關信息

行業排名
28 / 382
全市場排名
124 / 4482
所屬行業
生物技術與醫療研究

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Azenta Inc亮點

亮點風險
Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入593.82M美元
估值高估
公司最新PE估值-4.25,處於3年歷史高位
機構減倉
最新機構持股52.28M股,環比減少8.52%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉13.35K股
活躍度增加
近期活躍度增加,過去20天平均換手率0.77

分析師目標

基於 7 分析師
買入
評級
28.500
目標均價
+69.64%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Azenta Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Azenta Inc簡介

Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
公司代碼AZTA
公司Azenta Inc
CEOMarotta (John)
網址https://www.azenta.com/
KeyAI